• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy House Republicans accuse NIH of ‘stonewalling’ on ‘supercharged monkeypox experiment’
Economy

House Republicans accuse NIH of ‘stonewalling’ on ‘supercharged monkeypox experiment’

by April 2, 2023
by April 2, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

House Republicans are pressing the National Institutes of Health (NIH) for answers after the agency funded research experiments they say could result in a ‘supercharged’ monkeypox virus. 

In a letter to acting NIH Director Lawrence Tabak, House Energy and Commerce Committee Chair Cathy McMorris Rodgers, R-Wash., and two subcommittee chairmen are demanding that the agency turn over documents and information regarding a government-funded experiment that reportedly involves swapping monkepox genes with a deadlier version of the virus. The lawmakers want to know whether this project was approved by the Department of Health and Human Services (HHS) review board tasked with oversight of research involving enhanced pathogens that could potentially cause a pandemic. 

This letter is a follow-up to an October 31, 2022, letter to which Republicans say the NIH never responded. GOP lawmakers accused NIH of ‘stonewalling’ in a press release. 

‘Based on the available information, it appears the project is reasonably anticipated to yield a lab-generated monkeypox virus that is 1,000 times more lethal in mice than the monkeypox virus currently circulating in humans and that transmits as efficiently as the monkeypox virus currently circulating in humans. The risk-benefit ratio indicates potentially serious risks without clear civilian practical applications,’ the Republicans wrote. 

‘Accordingly, this experiment would seem to involve risks reasonably anticipated to create, transfer, or use [potential pandemic pathogens] resulting from the enhancement of a pathogen’s transmissibility or virulence in humans. Thus, under the circumstances, we are interested in learning whether this experiment was reviewed under the HHS P3CO framework used to review research proposals posing significant biosafety or biosecurity risks.’ 

The project leader is Dr. Bernard Moss, a veteran poxvirus researcher at the U.S. National Institute of Allergy and Infectious Diseases. An article in Science magazine described his efforts to learn the differences between two variants of monkeypox virus: clade 2, the West African variant that caused a global outbreak last year, and clade 1, which is believed to be deadlier and has caused outbreaks in the Democratic Republic of Congo for decades. 

Moss’ research involves swapping the genes of the two variants, one at a time, to discover whether a specific gene in the clade 1 virus makes it deadlier. The Republicans want to know whether these lab experiments could artificially enhance the clade 2 variant. 

Such research, known as ‘gain-of-function,’ is highly controversial, because it involves extracting viruses from animals to artificially engineer in a laboratory to make them more transmissible and deadly to humans. Proponents say these experiments can help scientists understand the nature of viruses and develop new treatments and vaccines. Skeptics warn that gain-of-function experiments are one lab accident away from causing another global pandemic. 

Moss did not immediately respond to a request for comment. 

‘Human disease associated with clade 2 or West African monkeypox virus infection is less severe and is associated with less than one percent mortality, whereas clade 1 or Congo Basin monkeypox infection has a 10 percent case fatality rate in unvaccinated persons,’ the Republicans wrote. ‘Because of its significantly greater lethality, clade 1 or Congo Basin clade monkeypox viruses are regulated as select agents by the Federal Select Agents Program. Entities that possess, use, or transfer this agent must comply with the HHS Select Agent and Toxin Regulations unless there is an applicable exemption or exclusion. 

‘Thus,’ the letter continues, ‘under these regulations, it would appear the clade 1 monkeypox virus experiment is a restricted experiment that must be reviewed by the Federal Select Agent Program, and may be further reviewed by the Centers for Disease Control and Prevention‘s (CDC’s) Intragovernmental Select Agents and Toxins Technical Advisory Committee (ISATTAC).’ 

The Republicans want NIH officials and employees to testify about Moss’ project and other related matters. They gave NIH an April 13, 2023, deadline to respond to their inquiry. 

Chris Pandolfo is a writer for Fox News Digital. Send tips to chris.pandolfo@fox.com and follow him on Twitter @ChrisCPandolfo.

This post appeared first on FOX NEWS
You Might Also Like
  • Wisconsin Gov. Evers appoints former Democratic state lawmaker to chair embattled parole commission
  • McConnell looks to cement legacy as ‘Reagan Republican’ with crusade for Ukraine support
  • Kids Online Safety Act reintroduced in Senate expected to pass with major support
  • Biden’s age much more of a liability than Trump’s, poll finds ahead of presidential debate
Share
0
FacebookTwitterPinterestWhatsapp

previous post
Week Ahead: NIFTY Defends Key Supports; Upside May Stay Capped Here In This Short 3-Day Week
next post
DeSantis targets Biden in swing state Pennsylvania, says Democratic Party ‘dead’ in Florida

You may also like

Gov. Kristi Noem expected to endorse Donald Trump for president...

September 8, 2023

Constitution Party nominee aiming to help Trump, ‘destroy’ Democratic Party

August 21, 2024

Consumer Confidence Rose and Inflation Expectations Fell in December

December 21, 2022

Republican Rep. Jim Banks scores major endorsement for Senate run...

September 27, 2023

Biden, Trump tied in crucial battleground state in potential 2024...

June 29, 2023

Whatever happened to … the investigations into the Chinese spy...

July 14, 2023

Freedom Caucus draws first battle lines in election year government...

August 12, 2024

Indiana legislators look to ban automatic fire-inducing ‘Glock switches’

March 21, 2023

Law enforcement brace as anti-Israel groups vow to bring tens...

August 15, 2024

Look past the tributes, Joe Biden has been shuffled aside...

August 20, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Week Ahead: NIFTY Stays In A Defined Range; Moving Past This Level Crucial For Resumption Of Upmove

      May 31, 2025
    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right Now

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025
    • Run Your Stock Portfolio Like a Pro Sports Team

      May 30, 2025
    • U.S. foreign tax bill sends jitters across Wall Street

      May 30, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,765 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,472 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,451 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,432 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,309 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,582)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • Week Ahead: NIFTY Stays In A Defined Range; Moving Past...

      May 31, 2025
    • Breakouts, Momentum & Moving Averages: 10 Must-See Stock Charts Right...

      May 31, 2025
    • Leadership Rotation Could Confirm Corrective Phase

      May 30, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,106)
    • Investing (538)
    • Stock (2,582)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    The Pilgrims’ Real Thanksgiving Lesson

    November 24, 2022

    Guts Stock Overview: Latest Trends and...

    October 4, 2024

    Biden’s food drop in Gaza masks a radical...

    March 8, 2024
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here